FDA approves Jevtana to treat men with prostate cancer
Links shared publicly online about this topic.
- 1,086total visits
FDA approves Jevtana to treat men with prostate cancer
View full resource at news-medical.net
Tags: Cancer, Chemotherapy, Prostate Cancer, Prostate, Drug, Men's Health, FDA, Prednisone
Most Recently Shared on June 18, 2010 at 8:59 am By:
Prostate Cancer: FDA approves Jevtana to treat men with prostate cancer: The U.S. Food and Drug Administration tod... http://bit.ly/9YV2yC
Also Shared By:
Med-Chemist: FDA approves new targeted therapy to treat men with advanced prostate cancer..
med-chemist.com — “Med-Chemist : "Quintessential Medicinal Chemistry" - A Medicinal Chemist's Perception...” View full resource at med-chemist.com
Most Recently Shared on May 4, 2011 at 8:33 am By:
john clay mchugh Doctor, Surgeon, Urologist, and Physician
FDA approves new targeted therapy to treat men with advanced prostate cancer.. (Med-Chemist): In continuation of... http://bit.ly/iYEEZT
New targeted therapy to treat men with advanced prostate cancer approved by FDA
prostate-report.org — “New targeted therapy to treat men with advanced prostate cancer approved by FDA” View full resource at prostate-report.org
Most Recently Shared on May 3, 2011 at 6:20 pm By:
john clay mchugh Doctor, Surgeon, Urologist, and Physician
New targeted therapy to treat men with advanced prostate cancer approved by FDA: Abiraterone, a new targeted the... http://bit.ly/mumfDk
FDA approves new targeted therapy to treat men with advanced prostate cancer
news-medical.net — “The Food and Drug Administration on Thursday approved abiraterone, a new targeted therapy in the class of androgen receptor blockers.” View full resource at news-medical.net
Most Recently Shared on May 3, 2011 at 7:56 am By:
Prostate Cancer: FDA approves new targeted therapy to treat men with advanced prostate cancer: The Food and Drug... http://bit.ly/kI3jac
BTG: FDA Approved ZYTIGA To Treat Men With Advanced Metastatic Prostate Cancer
rttnews.com — “Specialist healthcare company BTG plc (BGC.L) noted the announcement by Centocor Ortho Biotech Inc, that the FDA has approved ZYTIGA, an oral, once-daily medication for use in combination with prednisone for the treatment of men with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel.” View full resource at rttnews.com
Most Recently Shared on May 3, 2011 at 7:42 am By:
BTG: FDA Approved ZYTIGA To Treat Men With Advanced Metastatic Prostate Cancer http://bit.ly/ljUAkD
FDA Approves Prostate Cancer Drug Zytiga | NewsBreakingOnline
newsbreakingonline.com — “The FDA has approved the Johnson & Johnson pill Zytiga for use in combination with the steroid prednisone to treat a certain type of late-stage prostate cancer in men who have already been treated with chemotherapy.” View full resource at newsbreakingonline.com
Most Recently Shared on April 29, 2011 at 8:37 am By:
john clay mchugh Doctor, Surgeon, Urologist, and Physician
FDA Approves Prostate Cancer Drug Zytiga (NewsBreakingOnline.com): The FDA has approved the Johnson & Johnson pi... http://bit.ly/ik6PMp
Jevtana (cabazitaxel) Injection Approved by U.S. FDA After Priority Review
drugs.com — “Jevtana (cabazitaxel) is used to treat prostate cancer. Includes Jevtana side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on June 22, 2010 at 12:31 am By:
Jevtana (cabazitaxel) Injection Approved by U.S. FDA After Priority Review - http://bit.ly/agHPRi
Jevtana FDA & Prostate Cancer Drug Approved
newsoxy.com — “FDA & prostate cancer drug approved using the name Jevtana. The Food and Drug Administration has approved a new medicine called Jevtana to treat the disease that affects men.” View full resource at newsoxy.com
Most Recently Shared on June 19, 2010 at 7:17 am By:
Jevtana FDA & Prostate Cancer Drug Approved http://bit.ly/c0JHHo
FDA approves Jevtana injection for prostate cancer - ONA
oncologynurseadvisor.com — “Sanofi-aventis announced that the FDA has approved Jevtana (cabazitaxel injection) in combination with prednisone for the treatment of patients with metastatic hormone-refractory prostate cancer (mHRPC) previously treated with a docetaxel-containing treatment regimen.” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 18, 2010 at 5:10 pm By:
OncologyNurseAdvisor Nursing, Medical Education, Medical Publisher, and Oncology
FDA approves Jevtana injection for prostate cancer http://goo.gl/fb/OVKFo
FDA approves Jevtana injection for prostate cancer - MPR
empr.com — “Sanofi-aventis announced that the FDA has approved Jevtana (cabazitaxel injection) in combination with prednisone for the treatment of patients with metastatic hormone-refractory prostate cancer (mHRPC) previously treated with a docetaxel-containing treatment regimen.” View full resource at empr.com
Most Recently Shared on June 18, 2010 at 4:57 pm By:
MPR News: FDA approves Jevtana injection for prostate cancer: Sanofi-aventis announced that the FDA has approved J... http://bit.ly/dac5L6
Prostate Cancer Drug Gets Approval - WSJ.com
online.wsj.com — “The Food and Drug Administration approved Jevtana, a Sanofi-Aventis chemotherapy drug used in combination with the steroid prednisone to treat men with prostate cancer.” View full resource at online.wsj.com
Most Recently Shared on June 18, 2010 at 1:51 am By:
Prostate Cancer Drug Gets Approval http://on.wsj.com/9iZKM9
Medical Minute 6-14: Prostate Cancer Vaccines Extend Lives
wctv.tv — “The first FDA-approved vaccine to treat prostate cancer is now available to patients. A second one is also in development. Doctors say the vaccines are changing the way they treat cancer. They're not cure-alls, but they could extend the lives of men who were only given a few years.” View full resource at wctv.tv
Most Recently Shared on June 14, 2010 at 9:58 pm By:
Medical Minute 6-14: Prostate Cancer Vaccines Extend Lives http://bit.ly/dwDuM2
FDA Approves Provenge - a Cellular Immunotherapy for Men With Advanced Prostate Cancer
drugs.com — “Provenge (sipuleucel-T) is used to treat advanced prostate cancer. Includes Provenge side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 29, 2010 at 10:41 pm By:
FDA Approves Provenge - a Cellular Immunotherapy for Men With Advanced Prostate Cancer - http://bit.ly/9KHZDo
Advertisement
News-Medical.Net
@NewsMedical
FDA approves Jevtana to treat men with prostate cancer: The U.S. Food and Drug Administration today approved Jevta... http://bit.ly/9YV2yC
1 year ago...